Showing results (51-60 of 181) with videos related to
Sort By:
Pageof 19
Annals of Internal Medicine|January 1, 2019
Fracture Risk After Initiation of Use of Canagliflozin: A Cohort StudyMichael Fralick, Seoyoung C Kim, Sebastian Schneeweiss, et al.Arthritis Care & Research|August 30, 2022
Using Data-Driven Approaches to Classify and Predict Health Care Spending in Patients With Gout Using Urate-Lowering TherapyJulie C Lauffenburger, Zhigang Lu, Mufaddal Mahesri, et al.Annals of the Rheumatic Diseases|November 20, 2015
Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claimsDaniel H Solomon, Chih-Chin Liu, I-Hsin Kuo, et al.European Heart Journal|September 11, 2021
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with goutEun Ha Kang, Eun Hye Park, Anna Shin, et al.Arthritis Care & Research|August 4, 2019
Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort StudyEun Ha Kang, Yinzhu Jin, Angela Y Tong, et al.Rheumatology (Oxford, England)|March 22, 2021
Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort studyRishi J Desai, Ajinkya Pawar, Farzin Khosrow-Khavar, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 1, 2022
Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) StudyFarzin Khosrow-Khavar, Rishi J Desai, Hemin Lee, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 5, 2019
Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus ErythematosusSara K Tedeschi, Seoyoung C Kim, Hongshu Guan, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 2, 2020
Risk of Incident Atrial Fibrillation With Zoledronic Acid Versus Denosumab: A Propensity Score-Matched Cohort StudyKristin M D'Silva, Sara Jane Cromer, Elaine W Yu, et al.Diabetes, Obesity & Metabolism|August 2, 2021
Validation of obesity-related diagnosis codes in claims dataKarine Suissa, Sebastian Schneeweiss, Kueiyu Joshua Lin, et al.Pageof 19